Bui Christina MD is categorized under Internal Medicine Doctors in Brownsville, TX and active since 2010.
Bui Christina MD was established in 2010, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Internal Medicine Doctors business, which does work in the B2C market, and is classified as a Internal Medicine Doctors, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact Christina Bui at the company’s single location by writing to 1058 East Los Ebanos Boulevard, Brownsville, Texas TX 78520 or by phoning (956) 541-4828. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Bui Christina MD |
| Contact Person: | Christina Bui |
| Address: | 1058 East Los Ebanos Boulevard, Brownsville, Texas 78520 |
| Phone Number: | (956) 541-4828 |
| Website Address: | theeyeexperts.com |
| Annual Revenue (USD): | $500.000 to $999.999 |
| Founded: | 2010 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Internal Medicine Doctors |
| SIC Code: | 8011 |
| NAICS Code: | 6211110 |
| Share This Business: |
Bui Christina MD was started in 2010 to provide professional Internal Medicine Doctors under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Christina Bui for inquiries that concern Bui Christina MD by calling the company number (956) 541-4828, as your correspondence is most welcome. Additionally, the physical location of the single location of Bui Christina MD can be found at the coordinates 25.93211,-97.50574 as well as the street address 1058 East Los Ebanos Boulevard in Brownsville, Texas 78520.
For its online presence, you may visit Bui Christina MD’s website at theeyeexperts.com and engage with its social media outlets through on Twitter and on Facebook.